Maleic Acid

Maleic Acid

SCHEMBL1664727

C=CC(=O)OC1CC2CCC1(C)C2(C)C.O=C(O)/C=C\C(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol

The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.59
ELANE P08246 2/20 0.54
MAPT P10636 2/20 0.49
KDM4E B2RXH2 1/20 0.49
GAA P10253 1/20 0.49
XBP1 P17861 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MAPK1 P28482 1/20 0.48
KMT2A Q03164 1/20 0.48
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid SCHEMBL8168043 0.94 CYP2C19 (0.58) CYP2C19ELANEMAPTKDM4EGAA
Acrylic Acid SCHEMBL20918477 0.94 CYP2C19 (0.58) CYP2C19ELANEMAPTKDM4EGAA
Acrylic Acid SCHEMBL1591920 0.94 CYP2C19 (0.58) CYP2C19ELANEMAPTKDM4EGAA
Acrylic Acid SCHEMBL27988742 0.94 CYP2C19 (0.58) CYP2C19ELANEMAPTKDM4EGAA
SCHEMBL26704 0.93 CYP2C19 (0.59) CYP2C19ELANEMAPTKDM4EGAA
SCHEMBL21838264 0.93 CYP2C19 (0.59) CYP2C19ELANEMAPTKDM4EGAA
SCHEMBL22902902 0.93 CYP2C19 (0.59) CYP2C19ELANEMAPTKDM4EGAA
SCHEMBL1185726 0.93 CYP2C19 (0.59) CYP2C19ELANEMAPTKDM4EGAA
SCHEMBL9227026 0.93 CYP2C19 (0.59) CYP2C19ELANEMAPTKDM4EGAA
SCHEMBL17917072 0.93 CYP2C19 (0.59) CYP2C19ELANEMAPTKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207144-A1 OIL-IN-WATER DESPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF Leading Edge Innovations, LLC (US) 2024-06-27 US claimed
CN-116997315-A Cosmetic composition for improving skin and use method thereof 莱雅公司 2023-11-03 CN claimed
CN-116887809-A Cosmetic composition for improving skin and use method thereof 莱雅公司 2023-10-13 CN claimed
CN-115315293-A Oral care compositions and methods of use 高露洁-棕榄公司 2022-11-08 CN claimed
US-20200268634-A1 EYE MAKE-UP COSMETIC COMPOSITION COMPRISING ACRYLATE-BASED COPOLYMER COSMAX, INC. (KR) 2020-08-27 US claimed
CN-111212629-A Ocular cosmetic composition comprising acrylate-based copolymer 科丝美诗株式会社 2020-05-29 CN claimed
US-6517823-B1 Thickener and wax such that the gloss effect is greater than 50% L'OREAL S.A. (FR) 2003-02-11 US claimed
EP-1253905-A1 HIGH GLOSS MASCARA L'OREAL (FR) 2002-11-06 EP claimed
WO-2001054660-A1 HIGH GLOSS MASCARA L'OREAL (FR) 2001-08-02 WO claimed
US-20240207148-A1 SPRAYABLE COMPOSITIONS CONTAINING OIL-IN-WATER EMULSIONS CONTAINING SUBMICRON HYDROPHOBIC AGENTS AND METHODS OF USE THEREOF Leading Edge Innovations, LLC (US) 2024-06-27 US disclosed
WO-2024137600-A1 SPRAYABLE COMPOSITIONS CONTAINING OIL-IN-WATER EMULSIONS CONTAINING SUBMICRON HYDROPHOBIC AGENTS AND METHODS OF USE THEREOF Leading Edge Innovations, LLC (US) 2024-06-27 WO disclosed
WO-2024137409-A1 OIL-IN-WATER EMULSIONS CONTAINING SUBMICRON HYDROPHOBIC AGENTS AND METHODS OF USE THEREOF Leading Edge Innovations, LLC (US) 2024-06-27 WO disclosed
WO-2024137539-A2 SPRAYABLE COMPOSITIONS CONTAINING OIL-IN-WATER DISPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF Leading Edge Innovations, LLC (US) 2024-06-27 WO disclosed
WO-2024137719-A1 SPRAYABLE SUNSCREEN COMPOSITIONS CONTAING OIL-IN-WATER EMULSIONS CONTAINING SUBMICRON HYDROPHOBIC AGENTS AND METHODS OF USE THEREOF Leading Edge Innovations, LLC (US) 2024-06-27 WO disclosed
WO-1999022697-A1 PERSONAL CARE COMPOSITIONS SUITABLE FOR STYLING HAIR THE PROCTER & GAMBLE COMPANY (US) 1999-05-14 WO disclosed
WO-1999022699-A1 PERSONAL CARE COMPOSITIONS SUITABLE FOR APPLICATION TO THE HAIR, SKIN OR NAILS THE PROCTER & GAMBLE COMPANY (US) 1999-05-14 WO disclosed
WO-1999022698-A1 PERSONAL CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-05-14 WO disclosed
WO-1999022702-A1 PERSONAL CARE COMPOSITIONS SUITABLE FOR STYLING HAIR THE PROCTER & GAMBLE COMPANY (US) 1999-05-14 WO disclosed
WO-1998051266-A1 FIXATIVE POLYMERS ISP INVESTMENTS INC. (US) 1998-11-19 WO disclosed
US-5160729-A N-alkyl pyrrolidone surfactant; curl retention, reduced droop and drag; low volatile organic compounds ISP INVESTMENTS INC. (US) 1992-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240207148-A1 SPRAYABLE COMPOSITIONS CONTAINING OIL-IN-WATER EMULSIONS CONTAINING SUBMICRON HYDROPHOBIC AGENTS AND METHODS OF USE THEREOF LIPA, MGLL, SGMS2 CYP2C19 2848/4885ELANE 31/4885MAPT 1884/4885
US-20240207144-A1 OIL-IN-WATER DESPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF HTT, LIPA, PIGS CYP2C19 3451/4885ELANE 240/4885MAPT 620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.